Get the Stockscreener App
14.00
1.41%
-0.20
After Hours:
13.80
-0.20
-1.43%
Avadel Pharmaceuticals Plc stock is traded at $14.00, with a volume of 875.37K.
It is down -1.41% in the last 24 hours and down -11.45% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$14.20
Open:
$14.25
24h Volume:
875.37K
Relative Volume:
0.68
Market Cap:
$1.36B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
280.00
EPS:
0.05
Net Cash Flow:
$5.89M
1W Performance:
-6.73%
1M Performance:
-11.45%
6M Performance:
+96.35%
1Y Performance:
+8.02%
1-Day Range:
$13.83
$14.27
1-Week Range:
$13.83
$15.20
52-Week Range:
$6.38
$16.66
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
14.00 | 1.38B | 221.08M | -2.92M | 5.89M | 0.05 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Q3 Earnings Forecast for AVDL Issued By Leerink Partnrs - MarketBeat
Should you hold or exit Avadel Pharmaceuticals plc nowTrade Analysis Report & Low Drawdown Investment Strategies - newser.com
Using economic indicators to assess Avadel Pharmaceuticals plc potentialEarnings Miss & Low Risk High Reward Ideas - newser.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
What drives Avadel Pharmaceuticals plc stock priceTrading Psychology Tips & Exceptional Profit Ideas - earlytimes.in
Avadel Pharmaceuticals plc stock trend forecastJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Using portfolio simulators with Avadel Pharmaceuticals plc includedPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock a contrarian opportunityJuly 2025 Price Swings & High Conviction Trade Alerts - newser.com
Volatility clustering patterns for Avadel Pharmaceuticals plc2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Can Avadel Pharmaceuticals plc (AWK) stock hold up in economic slowdownMarket Risk Analysis & Real-Time Volume Trigger Notifications - newser.com
Is Avadel Pharmaceuticals plc stock a defensive play in 2025July 2025 Sector Moves & Safe Entry Point Alerts - newser.com
Analysts Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Breakeven Soon - Yahoo Finance
Custom strategy builders for tracking Avadel Pharmaceuticals plcDollar Strength & Safe Capital Growth Trade Ideas - newser.com
How strong is Avadel Pharmaceuticals plc (AWK) stock earnings growthMarket Performance Report & Community Shared Stock Ideas - newser.com
Can Avadel Pharmaceuticals plc stock withstand economic slowdownMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com
Why Avadel Pharmaceuticals plc (AWK) stock trades below fair valueJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com
Is Avadel Pharmaceuticals plc stock attractive after correctionRisk Management & Daily Entry Point Alerts - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock good for long term investingWeekly Trade Recap & Precise Buy Zone Identification - newser.com
How to build a custom watchlist for Avadel Pharmaceuticals plcWeekly Market Outlook & Momentum Based Trading Ideas - newser.com
Is Avadel Pharmaceuticals plc a good long term investmentCovered Call Writing & Make Confident Moves With Forecasting Models - earlytimes.in
Will Avadel Pharmaceuticals plc stock maintain dividend yieldQuarterly Growth Report & AI Driven Stock Reports - newser.com
Avadel: Mispriced Leader In Once-Nightly Sleep Therapies - Seeking Alpha
What analysts say about Avadel Pharmaceuticals plc stockBollinger Bands Signals & Free Stock Trading Signal Access - earlytimes.in
Avadel Pharmaceuticals gains as holder pushes for sale process - MSN
Does Avadel Pharmaceuticals plc fit your quant trading modelMarket Weekly Review & Verified Chart Pattern Trade Signals - newser.com
Avadel Pharmaceuticals plc AWK Stock Analysis and ForecastMarket Sentiment Extremes & Small Investment Capital Tips - earlytimes.in
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Institutional Investors Lost 5.3% Last Week but Have Benefitted From Longer-term Gains - 富途牛牛
Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz - MSN
Why The Story Around Avadel Pharmaceuticals Is Evolving After Recent Analyst and Market Updates - Sahm
Avadel Pharmaceuticals (NASDAQ:AVDL) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avadel Pharmaceuticals Plc Stock (AVDL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
| Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
| Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
| Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
| Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):